Literature DB >> 19114891

N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial.

Prakaykaew Charunwatthana1, M Abul Faiz, Ronnatrai Ruangveerayut, Richard J Maude, M Ridwanur Rahman, L Jackson Roberts, Kevin Moore, Emran Bin Yunus, M Gofranul Hoque, Mahatab Uddin Hasan, Sue J Lee, Sasithon Pukrittayakamee, Paul N Newton, Nicholas J White, Nicholas P J Day, Arjen M Dondorp.   

Abstract

OBJECTIVE: Markers of oxidative stress are reported to be increased in severe malaria. It has been suggested that the antioxidant N-acetylcysteine (NAC) may be beneficial in treatment. We studied the efficacy and safety of parenteral NAC as an adjunct to artesunate treatment of severe falciparum malaria.
DESIGN: A randomized, double-blind, placebo-controlled trial on the use of high-dose intravenous NAC as adjunctive treatment to artesunate.
SETTING: A provincial hospital in Western Thailand and a tertiary referral hospital in Chittagong, Bangladesh. PATIENTS: One hundred eight adult patients with severe falciparum malaria.
INTERVENTIONS: Patients were randomized to receive NAC or placebo as an adjunctive treatment to intravenous artesunate.
MEASUREMENTS AND MAIN RESULTS: A total of 56 patients were treated with NAC and 52 received placebo. NAC had no significant effect on mortality, lactate clearance times (p = 0.74), or coma recovery times (p = 0.46). Parasite clearance time was increased from 30 hours (range, 6-144 hours) to 36 hours (range, 6-120 hours) (p = 0.03), but this could be explained by differences in admission parasitemia. Urinary F2-isoprostane metabolites, measured as a marker of oxidative stress, were increased in severe malaria compared with patients with uncomplicated malaria and healthy volunteers. Admission red cell rigidity correlated with mortality, but did not improve with NAC.
CONCLUSION: Systemic oxidative stress is increased in severe malaria. Treatment with NAC had no effect on outcome in patients with severe falciparum malaria in this setting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19114891      PMCID: PMC2731834          DOI: 10.1097/CCM.0b013e3181958dfd

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  41 in total

Review 1.  Abnormal blood flow and red blood cell deformability in severe malaria.

Authors:  A M Dondorp; P A Kager; J Vreeken; N J White
Journal:  Parasitol Today       Date:  2000-06

Review 2.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

3.  Malarial anaemia in African children associated with high oxygen-radical production.

Authors:  B Greve; P G Kremsner; B Lell; D Luckner; D Schmid
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

4.  Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione.

Authors:  J D Morrow; L J Roberts; V C Daniel; J A Awad; O Mirochnitchenko; L L Swift; R F Burk
Journal:  Arch Biochem Biophys       Date:  1998-05-01       Impact factor: 4.013

5.  Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria.

Authors:  M J Griffiths; F Ndungu; K L Baird; D P Muller; K Marsh; C R Newton
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

6.  N-acetylcysteine in severe falciparum malaria in Thailand.

Authors:  Sombat Treeprasertsuk; Srivicha Krudsood; Thanawat Tosukhowong; Wirach Maek-A-Nantawat; Suparp Vannaphan; Tosaporn Saengnetswang; Sornchai Looareesuwan; Walter F Kuhn; Gary Brittenham; James Carroll
Journal:  Southeast Asian J Trop Med Public Health       Date:  2003-03       Impact factor: 0.267

7.  Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice.

Authors:  C M Thumwood; N H Hunt; W B Cowden; I A Clark
Journal:  Br J Exp Pathol       Date:  1989-06

8.  A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria.

Authors:  T H Tran; N P Day; H P Nguyen; T H Nguyen; T H Tran; P L Pham; X S Dinh; V C Ly; V Ha; D Waller; T E Peto; N J White
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

9.  The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis.

Authors:  Ross L Paterson; Helen F Galley; Nigel R Webster
Journal:  Crit Care Med       Date:  2003-11       Impact factor: 7.598

10.  N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report.

Authors:  Ortrud Vargas Hein; Renate Ohring; Andreas Schilling; Michael Oellerich; Victor W Armstrong; Wolfgang J Kox; Claudia Spies
Journal:  Crit Care       Date:  2004-01-22       Impact factor: 9.097

View more
  41 in total

Review 1.  The role of antioxidants treatment on the pathogenesis of malarial infections: a review.

Authors:  Murtala Bindawa Isah; Mohammed Auwal Ibrahim
Journal:  Parasitol Res       Date:  2014-02-13       Impact factor: 2.289

Review 2.  Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.

Authors:  Chandy C John; Elizabeth Kutamba; Keith Mugarura; Robert O Opoka
Journal:  Expert Rev Anti Infect Ther       Date:  2010-09       Impact factor: 5.091

3.  Cytoadherence and severe malaria.

Authors:  Alister G Craig; Mohd Fadzli Mustaffa Khairul; Pradeep R Patil
Journal:  Malays J Med Sci       Date:  2012-04

4.  Role of Coma Acidosis Malaria Score in Patients with Severe Malaria among Indian Population: a Tertiary Care Center Experience.

Authors:  Hari Krishan Aggarwal; Deepak Jain; Avinash Rao; Rajinish Kalra
Journal:  Eurasian J Med       Date:  2017-02

5.  CMCH and MORU: a Highly Successful Collaboration.

Authors:  Richard J Maude; Emran Bin Yunus; Gofranul Hoque; Mahtab Uddin Hassan; Amir Hossain; Rasheda Samad; Ridwanur Rahman; Aniruddha Ghose; Nicholas P Day; Nicholas J White; Arjen M Dondorp; M Abul Faiz
Journal:  J Chittagong Med Coll Teach Assoc       Date:  2010-05

Review 6.  Cerebral malaria--clinical manifestations and pathogenesis.

Authors:  Rachna Hora; Payal Kapoor; Kirandeep Kaur Thind; Prakash Chandra Mishra
Journal:  Metab Brain Dis       Date:  2016-01-08       Impact factor: 3.584

7.  Antioxidant therapy: reducing malaria severity?

Authors:  Hans C Ackerman; Steven D Beaudry; Rick M Fairhurst
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

8.  A simple score to predict the outcome of severe malaria in adults.

Authors:  Josh Hanson; Sue J Lee; Sanjib Mohanty; M A Faiz; Nicholas M Anstey; Prakaykaew Charunwatthana; Emran Bin Yunus; Saroj K Mishra; Emiliana Tjitra; Ric N Price; Ridwanur Rahman; Francois Nosten; Ye Htut; Gofranul Hoque; Tran Thi Hong Chau; Nguyen Hoan Phu; Tran Tinh Hien; Nicholas J White; Nicholas P J Day; Arjen M Dondorp
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

9.  A new hypothesis on the manifestation of cerebral malaria: the secret is in the liver.

Authors:  Yuri Chaves Martins; Cláudio Tadeu Daniel-Ribeiro
Journal:  Med Hypotheses       Date:  2013-08-13       Impact factor: 1.538

10.  L-cysteine whether a nutritional booster or a radical scavenger for Plasmodium.

Authors:  Shweta Sinha; C S Gautam; Rakesh Sehgal
Journal:  Trop Parasitol       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.